Cite
RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular carcinoma via the Wnt/β-catenin-ferroptosis axis.
MLA
Li, Zhili, et al. “RNA Helicase DDX5 Modulates Sorafenib Sensitivity in Hepatocellular Carcinoma via the Wnt/β-Catenin-Ferroptosis Axis.” Cell Death & Disease, vol. 14, no. 11, Nov. 2023, p. 786. EBSCOhost, https://doi.org/10.1038/s41419-023-06302-0.
APA
Li, Z., Caron de Fromentel, C., Kim, W., Wang, W.-H., Sun, J., Yan, B., Utturkar, S., Lanman, N. A., Elzey, B. D., Yeo, Y., Zhang, H., Kazemian, M., Levrero, M., & Andrisani, O. (2023). RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular carcinoma via the Wnt/β-catenin-ferroptosis axis. Cell Death & Disease, 14(11), 786. https://doi.org/10.1038/s41419-023-06302-0
Chicago
Li, Zhili, Claude Caron de Fromentel, Woojun Kim, Wen-Hung Wang, Jiazeng Sun, Bingyu Yan, Sagar Utturkar, et al. 2023. “RNA Helicase DDX5 Modulates Sorafenib Sensitivity in Hepatocellular Carcinoma via the Wnt/β-Catenin-Ferroptosis Axis.” Cell Death & Disease 14 (11): 786. doi:10.1038/s41419-023-06302-0.